DiaSorin, Inc. · Class II · Cleared Jul 26, 2022
| K-number | K213858 |
| Device name | LIAISON Calprotectin, LIAISON Q.S.E.T. Device Plus |
| Applicant | DiaSorin, Inc. |
| Product code | NXO |
| Device class | Class II |
| Decision date | Jul 26, 2022 |
| Decision | Substantially Equivalent |
| Regulation | 866.5180 |
AI extraction for this record is queued and will appear within 24 hours. View full FDA record →
View the full FDA submission: accessdata.fda.gov